Certain Blood Types Could Be Associated with Greater Risk of Contracting COVID-19, Confirms New Study
By HospiMedica International staff writers Posted on 04 Mar 2021 |
Illustration
As researchers around the world work to identify and address risk factors for severe COVID-19, there is additional evidence that certain blood types could be associated with greater risk of contracting the disease.
The findings of one of the first laboratory studies conducted by researchers at Brigham and Women’s Hospital (Boston, MA, USA) suggest that SARS-CoV-2, the virus that causes COVID-19, is particularly attracted to the blood group A antigen found on respiratory cells. In the study, researchers assessed a protein on the surface of the SARS-CoV-2 virus called the receptor binding domain, or RBD. The RBD is the part of the virus that attaches to the host cells, so it is an important research target for understanding how infection occurs. The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type. They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells. It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells. The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.
Based on their observations, the team sought to determine whether a similar binding preference existed for the RBD of SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). Although the makeup of the virus differs, the SARS-CoV RBD exhibited the same preference to bind to the group A antigens on respiratory cells. The team has emphasized that their findings alone could not fully describe or predict how coronaviruses like SARS-CoV-2 and SARS-CoV would affect patients of various blood types. While further research is needed to understand that influence, the research adds to findings from earlier studies suggesting a possible link between blood type and COVID-19 susceptibility and severity.
“It is interesting that the viral RBD only really prefers the type of blood group A antigens that are on respiratory cells, which are presumably how the virus is entering most patients and infecting them,” said study author Sean R. Stowell, MD, PhD, of Brigham and Women’s Hospital. “Blood type is a challenge because it is inherited and not something we can change. But if we can better understand how the virus interacts with blood groups in people, we may be able to find new medicines or methods of prevention.”
Related Links:
Brigham and Women’s Hospital
The findings of one of the first laboratory studies conducted by researchers at Brigham and Women’s Hospital (Boston, MA, USA) suggest that SARS-CoV-2, the virus that causes COVID-19, is particularly attracted to the blood group A antigen found on respiratory cells. In the study, researchers assessed a protein on the surface of the SARS-CoV-2 virus called the receptor binding domain, or RBD. The RBD is the part of the virus that attaches to the host cells, so it is an important research target for understanding how infection occurs. The team assessed synthetic blood group antigens on respiratory and red blood cells found in blood group A, B, and O individuals, and analyzed how the SARS-CoV-2 RBD interacted with each unique blood type. They discovered that the RBD had a strong preference for binding to blood group A found on respiratory cells. It did not display a preference for blood group A red blood cells, or other blood groups found on respiratory or red cells. The capacity of the RBD to preferentially recognize and attach to the blood type A antigen found in the lungs of blood type A individuals may provide insight into the potential link between blood group A and COVID-19 infection.
Based on their observations, the team sought to determine whether a similar binding preference existed for the RBD of SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). Although the makeup of the virus differs, the SARS-CoV RBD exhibited the same preference to bind to the group A antigens on respiratory cells. The team has emphasized that their findings alone could not fully describe or predict how coronaviruses like SARS-CoV-2 and SARS-CoV would affect patients of various blood types. While further research is needed to understand that influence, the research adds to findings from earlier studies suggesting a possible link between blood type and COVID-19 susceptibility and severity.
“It is interesting that the viral RBD only really prefers the type of blood group A antigens that are on respiratory cells, which are presumably how the virus is entering most patients and infecting them,” said study author Sean R. Stowell, MD, PhD, of Brigham and Women’s Hospital. “Blood type is a challenge because it is inherited and not something we can change. But if we can better understand how the virus interacts with blood groups in people, we may be able to find new medicines or methods of prevention.”
Related Links:
Brigham and Women’s Hospital
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans